期刊文献+

药物浸浴治疗重症皮肤病的效果观察 被引量:3

药物浸浴治疗重症皮肤病的效果观察
下载PDF
导出
摘要 目的观察分析药物浸浴治疗重症皮肤病的方法和效果。方法选取84例重症皮肤病患者为研究对象,随即将患者分为2组,治疗组和对照组各42例,对照组给予常规高锰酸钾清洁创面,治疗组根据患者的皮损程度给予高锰酸钾浴和淀粉浴,每日1次。观察2组患者的临床疗效、病死率、住院时间等差异。结果 2组患者在总有效率、住院时间及病死率差异均有统计学意义(P<0.05)。结论重症皮肤病患者采用药物浸浴治疗能够较好改善患者病情,降低病死率,临床疗效显著,能够较好的促进重症皮肤病早期康复。 Objective To observe the analysis of drug bath in the treatment for severe skin disease and the effect of the method. Methods 84 cases of patients with severe skin disease as the object of study, the patients were divided into two groups, the treatment group and the control group with 42 cases in each group, the control group was given routine treatment group according to potassium permanganate clean wound,skin lesions of patients with a given degree of potassium permanganate bath and starch bath,once a day.Observation of the clinical curative effect of two groups of patients, mortality, hospitalization time difference.Results The two groups of patients in total effective rate, duration of hospitalization and mortality rate of the differences were statistically significant (P0.05).Conclusion Patients with severe skin disease with drug bath treatment can improve the patient's condition, reduce the mortality rate, obvious curative effect, which can better promote early rehabilitation of severe skin disease.
作者 何盾
出处 《中外医疗》 2011年第35期4-5,共2页 China & Foreign Medical Treatment
关键词 重症皮肤病 药物浸浴 临床疗效 Severe skin disease Drug bath Clinical efficacy
  • 相关文献

参考文献5

二级参考文献25

  • 1冯素英,靳培英.静脉滴注免疫球蛋白治疗皮肤病的现状[J].中华皮肤科杂志,2005,38(6):396-398. 被引量:24
  • 2王庆伦,鲍廷锋,许军.清瘟败毒饮的药理作用与临床应用概况[J].江西中医学院学报,1995,7(4):39-40. 被引量:18
  • 3朱国兴,陆春,赖维,冯佩英,顾有守.大剂量静脉注射免疫球蛋白治疗25例重症皮肤病的临床分析[J].中华皮肤科杂志,2006,39(1):41-43. 被引量:21
  • 4Ibanez C,Montoro-Ronsano JB.Intravenous immunoglobulin preparations and autoimmune disorders:mechanisms of action.Curr Pharm Biotechnol,2003,4:239-247.
  • 5Mydlarski PR,Mittmann N,Shear NH.Intravenous immunoglobulin:use in dermatology.Skin Therapy Lett,2004,9:1-6.
  • 6Ahmed AR,Dahl MV.Consensus statement on the use of intravenous immunoglobulin therapy in the treatment of autoimmune mucocutaneous blistering diseases.Arch Dermatol,2003,139:1051-1059.
  • 7Mydlarski PR,Mittmann N,Shear NH.Intravenous immunoglobulin:use in dermatology[J].Skin Therapy Lett,2004,9:1-6.
  • 8Rutter A, Luger TA. High-dose intravenous immunoglobulins: an approach to treat severe immune-mediated and autoimmune diseases of the skin. J Am Acad Dermatol,2001, 44: 1010-1024.
  • 9Pyne D, Ehrenstein M, Morris V.The therapeutic uses of intravenous immunoglobulins in autoimmune rheumatic diseases.Rheumatology (Oxford). 2002, 41: 367-374.
  • 10Gelfand EW. Use of IGIV in the treatment of immune-mediated dermatologic disorders.J Investig Dermatol Symp Proc, 2004, 9:92-96.

共引文献42

同被引文献44

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部